GHRP-6 10mg

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided. For research use only – not for human or veterinary use.   Product Overview GHRP-6 is a research peptide belonging to the growth-hormone releasing peptide family, examined for its relevance to GH-axis modulation, pituitary signalling and appetite-related biochemical pathways. This lyophilized 10 mg peptide enables controlled laboratory evaluation of purity, identity and mechanistic response modelling.   Peptide Overview Between 2010 and 2025 GHRP-6 has been a key research compound for modelling ghrelin-receptor activity, comparing GHRP-class behaviours and investigating short-acting GH-modulation. Its defined analytical profile supports reproducible in-vitro applications.   Historical Background and Scientific Context GHRP-6 became widely studied from 2014 onward as laboratories explored GH-modulation, receptor cross-reactivity and the biochemical interplay between GHRP peptides and metabolic pathways. Its consistent purity profile and methodological reproducibility make it a reference molecule for comparative modelling.   Mechanistic Focus in Research

• GH-axis modelling and pituitary receptor interaction
• In-vitro ghrelin-mimetic pathway interpretation
• Biochemical comparison of GHRP-class peptides
• Metabolic and appetite-related pathway modelling
• Controlled structure–function peptide analysis

  Analytical Verification (COA) Independent Liquilabs analysis confirms full analytical validation for Batch GF092025034. Key results include:

• Assay Content: 10.53 mg
• Identification – Retention Time: 0.998
• Identification – Spectrum: 997
• Purity: 99.8 percent
• Endotoxins: below 0.001 EU per mg
• Microbial Growth: not detected for aerobic count yeast or mold
• Heavy Metals: not detected including arsenic cadmium lead mercury nickel cobalt vanadium

All analytical values originate from validated chromatographic, spectroscopic and microbiological procedures ensuring clean documentation and traceability.   Research Applications

• Growth-hormone secretagogue pathway evaluation
• Ghrelin-receptor modelling and metabolic signalling studies
• Comparative GHRP-class peptide research
• In-vitro appetite-regulation pathway modelling
• Biochemical modelling under controlled laboratory conditions

 

Grail Formula Quality

Every Grail Formula research peptide undergoes independent laboratory testing for purity, identity, structural integrity and microbial safety. All batches are verified for stability, low endotoxin levels and reproducibility to ensure reliable scientific outcomes.

When You Choose Grail Formula…

Researchers receive fully documented peptides with batch-number traceability, sealed-vial integrity and transparent laboratory verification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use

• Verified and analysed with Liquilabs s.r.o. Czechia
• 99.8 percent purity with validated assay content
• No detectable heavy metals or microbial contamination
• Endotoxin below 0.001 EU per mg
• Batch GF092025034 – Published October 2025
• EU shipments include bacteriostatic water
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.